Repara Silver Nitrate

Manufacturer
PSS World Medical, Inc. | Bray Group Limited
Effective date
2012-10-26
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:16:12

Label at a glance#

ProductRepara Silver Nitrate Applicators
Active ingredientSILVER NITRATE, POTASSIUM NITRATE
Label structure10 sections

Indications and uses

Repara ® ​Silver Nitrate Applicators are useful for cauterization of skin or mucous membrane and for the removal of granulation tissue, warts and verrucae.

Storage and handling

Store at room temperature in the closed package, in a dry place protected from light. Exposure to light will cause the silver nitrate tip to turn black, but will not affect the product's potency.

Label contents#

Full prescribing information#

Active Ingredients

COMPONENTS

Active Ingredients

Each flexible plastic applicator contains:

Silver Nitrate.............................75%

Potassium Nitrate.....................25%

CAUTION:

WARNINGS SECTION

Federal (USA) law restricts this device to sale by or on the order of a physician.

DOSAGE & ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Prior to use, the applicator stick may be bent or shaped to allow easier access to the target area. The medicated end of the applicator should be moistened in clean water and applied to the affected tissue. One applicator is normally sufficient for each application. The strength of the action is controlled by the amount of water used to moisten the tip. The applicator action can be stopped by washing the area with a saline solution (0.9% sodium chloride).

USES:

INDICATIONS & USAGE SECTION

Repara® ​Silver Nitrate Applicators are useful for cauterization of skin or mucous membrane and for the removal of granulation tissue, warts and verrucae.

CONTRAINDICATIONS & ANTIDOTES:

CONTRAINDICATIONS SECTION

Repara® Silver Nitrate Applicators must not be used for genital warts. Continued application to mucous membranes and open wounds leads to argyria, a blush-black discoloration of the skin due to depositions of granules of silver compounds in the connective tissues. This condition persists indefinitely or disappears very slowly. Poisoning by oral ingestion is unlikely with the quantities involved, but treatment for poisoning is the immediate ingestion of large amounts of salt water followed by an emetic. Then administer a dose of Epsom salts followed with milk. Immediately call a physician.

CAUTION:

USER SAFETY WARNINGS SECTION

KEEP OUT OF REACH OF CHILDREN. DO NOT USE ON OR NEAR EYES.

STORAGE:

STORAGE AND HANDLING SECTION

Store at room temperature in the closed package, in a dry place protected from light. Exposure to light will cause the silver nitrate tip to turn black, but will not affect the product's potency.

Comment or Questions?

USER SAFETY WARNINGS SECTION

Call (800) 777-4908

Manufacturing Information

SPL UNCLASSIFIED SECTION

Made in England

Manufactured for PSS World Medical, Inc.

4345 Southpoint Blvd.

Jacksonville, FL 32216

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

1655 Each

1655 Each1655 Each

1655 Case

1655 Case1655 Case

1655 Box

1655 Box1655 Box

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1117536potassium nitrate 25 % / silver nitrate 75 % Medicated PadPSN1
1117536potassium nitrate 250 MG/ML / silver nitrate 750 MG/ML Medicated PadSCD1
1117536K+ nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated PadSY1
1117536Pot nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated PadSY1
1117536potassium nitrate 25 % / silver nitrate 75 % Topical SpongeSY1
1117536potassium nitrate 25 % / silver nitrate 75 % Topical StickSY1
1117536potassium nitrate 25 % / silver nitrate 75 % Topical SwabSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6cca4355-1206-91f7-02de-17eef38a8622Product name120140508
751c581a-bf64-2fd7-b3ec-ca02c83e4a00Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68345-100-602019-11-27C16284748780-19855d018-ed3b-cd31-e053-dbdaa90ab51aREPARA (Silver Nitrate Applicators)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68345-100-60Repara Silver NitrateApplicators10 in 1 CASESTICK101
68345-100-60Repara Silver NitrateApplicators10 in 1 BOXSTICK101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68345-100REPARA SILVER NITRATE APPLICATORS (SILVER NITRATE) STICK [PSS WORLD MEDICAL, INC.]1Legacy NDC, 2 package rows20121027_0e989b78-893a-4776-b46e-6dd4c651a58d.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
POTASSIUM NITRATEACTIVE INGREDIENTRU45X2JN0Z1
SILVER NITRATEACTIVE INGREDIENT95IT3W8JZE1
NITRATE IONACTIVE MOIETYT93E9Y28441
SILVER CATIONACTIVE MOIETY57N7B0K90A1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68345-10068345-100-60

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
SILVER NITRATE95IT3W8JZEACTIB
POTASSIUM NITRATERU45X2JN0ZACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d73bfd7c-502e-4f10-a0bb-e625deb2b8530e989b78-893a-4776-b46e-6dd4c651a58d2012-10-26WarningsExact identifier
spl id: d73bfd7c-502e-4f10-a0bb-e625deb2b853
spl set id: 0e989b78-893a-4776-b46e-6dd4c651a58d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.